2024-12-27 03:41:17
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
Health/ 2023-07-22
Invivoscribe Announces FDA Approval of t...

SAN DIEGO,July 21,2023-- Invivoscribe is excited to announce that the LeukoStrat®CDx FLT3 Mutation Assay has been approved by the U.S. F...

Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
Corporate/ 2023-07-24
Mabwell Announces the NMPA Approval of N...

SHANGHAI,July 22,2023-- Mabwell (688062.SH),an innovative biopharmaceutical company with entire industry chain,announced that its clinical t...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release